Skip to content
10-Q

Quarterly Report

MARRONE BIO INNOVATIONS INC.

0001493152-21-027856

← back to feed
Filed
Nov 10, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 5, 2021 177.15M sh
Capex Q3 2021 · Sep 30, 2021 $905K
Capex Q3 2021 · Sep 30, 2020 $458K
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$6.57M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$8.6M
Long Term Debt Q3 2021 · Sep 30, 2021 $11.2M
Long Term Debt Q3 2021 · Dec 31, 2020 $11.48M
Short Term Debt Q3 2021 · Sep 30, 2021 $10.48M
Short Term Debt Q3 2021 · Dec 31, 2020 $9.3M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $15.05M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $15.84M
Stockholders Equity Q3 2021 · Sep 30, 2021 $30.63M
Stockholders Equity Q3 2021 · Jun 30, 2021 $34.68M
Stockholders Equity Q3 2021 · Mar 31, 2021 $35.35M
Stockholders Equity Q3 2021 · Dec 31, 2020 $31.41M
Stockholders Equity Q3 2021 · Sep 30, 2020 $23.11M
Stockholders Equity Q3 2021 · Jun 30, 2020 $26.1M
Stockholders Equity Q3 2021 · Mar 31, 2020 $24.86M
Stockholders Equity Q3 2021 · Dec 31, 2019 $23.56M
Current Liabilities Q3 2021 · Sep 30, 2021 $27.39M
Current Liabilities Q3 2021 · Dec 31, 2020 $24.23M
Total Liabilities Q3 2021 · Sep 30, 2021 $51.51M
Total Liabilities Q3 2021 · Dec 31, 2020 $49.79M
Current Assets Q3 2021 · Sep 30, 2021 $37.42M
Current Assets Q3 2021 · Dec 31, 2020 $34.26M
Total Assets Q3 2021 · Sep 30, 2021 $82.14M
Total Assets Q3 2021 · Dec 31, 2020 $81.2M
Sga Expense Q3 2021 · Sep 30, 2021 $7.26M
Sga Expense Q3 2021 · Sep 30, 2021 $22.03M
Sga Expense Q3 2021 · Sep 30, 2020 $7.34M
Sga Expense Q3 2021 · Sep 30, 2020 $22.41M
Rd Expense Q3 2021 · Sep 30, 2021 $2.99M
Rd Expense Q3 2021 · Sep 30, 2021 $7.86M
Rd Expense Q3 2021 · Sep 30, 2020 $2.86M
Rd Expense Q3 2021 · Sep 30, 2020 $7.82M
Net Income Q3 2021 · Sep 30, 2021 −$4.95M
Net Income Q3 2021 · Sep 30, 2021 −$11.24M
Net Income Q3 2021 · Jun 30, 2021 −$3.04M
Net Income Q3 2021 · Mar 31, 2021 −$3.26M
Net Income Q3 2021 · Sep 30, 2020 −$6.06M
Net Income Q3 2021 · Sep 30, 2020 −$15.96M
Net Income Q3 2021 · Jun 30, 2020 −$2.87M
Net Income Q3 2021 · Mar 31, 2020 −$7.02M
Operating Income Q3 2021 · Sep 30, 2021 −$4.41M
Operating Income Q3 2021 · Sep 30, 2021 −$9.79M
Operating Income Q3 2021 · Sep 30, 2020 −$5.45M
Operating Income Q3 2021 · Sep 30, 2020 −$13.11M
Gross Profit Q3 2021 · Sep 30, 2021 $6.05M
Gross Profit Q3 2021 · Sep 30, 2021 $20.79M
Gross Profit Q3 2021 · Sep 30, 2020 $5M
Gross Profit Q3 2021 · Sep 30, 2020 $17.96M
Cost Of Revenue Q3 2021 · Sep 30, 2021 $3.81M
Cost Of Revenue Q3 2021 · Sep 30, 2021 $12.71M
Cost Of Revenue Q3 2021 · Sep 30, 2020 $3.83M
Cost Of Revenue Q3 2021 · Sep 30, 2020 $12.7M
Revenue Q3 2021 · Sep 30, 2021 $9.86M
Revenue Q3 2021 · Sep 30, 2021 $33.49M
Revenue Q3 2021 · Sep 30, 2020 $8.83M
Revenue Q3 2021 · Sep 30, 2020 $30.66M